Tenon Medical, Inc. (TNON): Nasdaq/NYSE listing notice — Tenon Medical receives Nasdaq notice of non-compliance with $1.00 minimum bid price; 180-day cure period until Aug 2026

Tenon Medical, Inc.

Nasdaq letter dated Feb 25, 2026: common stock failed to maintain $1.00 bid price for 30 consecutive business days.
Company has until Aug 24, 2026 to regain compliance by closing at $1.00+ for 10 consecutive business days.
If not cured, may qualify for additional 180-day period by meeting other listing standards and intending to reverse split.
No immediate impact on listing; stock continues to trade under symbol TNON.
Management is evaluating options, including reverse stock split, to regain compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Tenon Medical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(b)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A), 5810(b)

Exact text from the filing

herein stating that for the 30 consecutive business day period between January 9, 2026 and February 24, 2026, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until August 24, 2026 (the “Compliance Period”), to regain compliance with the Bid Price Rule. To regain compliance, the closing bid price of the Comp

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Tenon Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-021682

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.